A recent cohort study published in the Journal of the American Medical Association delved into managing gram-negative bloodstream infections (GN-BSIs) across 24 hospitals in the United States, ...
Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for ...
Ofloxacin (Oflomac IV) is a fluoroquinolone antibiotic, prescribed for certain types of bacterial infections such as chronic bronchitis, pneumonia, skin and skin structure infections, and others.It ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback